Home
Scholarly Works
VRDN-001, a full antagonist antibody to IGF-1...
Journal article

VRDN-001, a full antagonist antibody to IGF-1 receptor: in vitro pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

Authors

Douglas R; Ugradar S; Turbin R; Cockerham K; Tang R; Nijhawan N; Kossler A; Boisvert C; Lee W; Yen M

Journal

Endocrine Abstracts, , ,

Publisher

Bioscientifica

Publication Date

August 24, 2023

DOI

10.1530/endoabs.92.op-09-01

ISSN

1470-3947
View published work (Non-McMaster Users)

Contact the Experts team